Brief: Hamlet Pharma In Discussions With Companies On LoI
17/11/2020 11:19
Nov 17 (Reuters) - Hamlet Pharma AB HAMLET.TE :
* IS CURRENTLY IN DISCUSSIONS WITH MAJOR MULTINATIONAL
COMPANIES
ON LETTERS OF INTENT INCLUDING EVALUATION- AND DEVELOPMENT OF
PROCESSES FOR A POTENTIAL, FUTURE COMMERCIAL USE OF BAMLET IN
NON-PRESCRIPTION AND FOOD PRODUCTS
Source text for Eikon: ID:nWkr80QcVQ
Further company coverage: HAMLET.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785110;))
Recent news on Hamlet BioPharma AB
See all newsBrief: Hamlet Biopharma Announces Completion Of Alpha1h Phase Ii Study In Non-Muscle Invasive Bladder Cancer
Brief: Hamlet Biopharma Holds Successful In Person Meeting With US FDA
Brief: Hamlet Pharma Q2 Loss Before Tax Narrows To SEK 2.8 Mln
Brief: Hamlet Pharma Gets Patent In Europe
Brief: Hamlet Pharma Gets Patent Granted In Europe